0.68 - 0.75
0.33 - 0.86
12.96M / 4.66M (Avg.)
34.50 | 0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-29.45%
Negative revenue growth while 0819.HK stands at 8.80%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-61.53%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-496.72%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-496.72%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-64.24%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-27.12%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-27.12%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
29.22%
Share count expansion well above 0819.HK's 0.73%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
29.28%
Diluted share count expanding well above 0819.HK's 0.24%. Michael Burry would fear significant dilution to existing owners' stakes.
-100.00%
Dividend reduction while 0819.HK stands at 147.56%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
-9.10%
Negative OCF growth while 0819.HK is at 107.72%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-2.79%
Negative FCF growth while 0819.HK is at 227.03%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
-48.70%
Negative 10Y revenue/share CAGR while 0819.HK stands at 1054.09%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-49.30%
Negative 5Y CAGR while 0819.HK stands at 190.96%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-53.69%
Negative 3Y CAGR while 0819.HK stands at 98.83%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
-963.10%
Negative 10Y OCF/share CAGR while 0819.HK stands at 5916.98%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-956.34%
Negative 5Y OCF/share CAGR while 0819.HK is at 62.07%. Joel Greenblatt would question the firm’s operational model or cost structure.
-34.05%
Negative 3Y OCF/share CAGR while 0819.HK stands at 201.02%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
-208.22%
Negative 10Y net income/share CAGR while 0819.HK is at 362.37%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-514.36%
Negative 5Y net income/share CAGR while 0819.HK is 200.99%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-282.74%
Negative 3Y CAGR while 0819.HK is 90.18%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
135.21%
Below 50% of 0819.HK's 300.42%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
-6.80%
Negative 5Y equity/share growth while 0819.HK is at 134.35%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
-26.90%
Negative 3Y equity/share growth while 0819.HK is at 73.10%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
-100.00%
Cut dividends over 10 years while 0819.HK stands at 543.23%. Joel Greenblatt suspects a weaker ability to return capital vs. the competitor.
-100.00%
Negative 5Y dividend/share CAGR while 0819.HK stands at 0.00%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
-100.00%
Negative near-term dividend growth while 0819.HK invests at 10.75%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
-5.13%
Firm’s AR is declining while 0819.HK shows 75.71%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
22.07%
Inventory growth well above 0819.HK's 16.97%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
9.37%
Asset growth well under 50% of 0819.HK's 21.50%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
-26.90%
We have a declining book value while 0819.HK shows 7.06%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
73.53%
Debt growth far above 0819.HK's 56.14%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
-37.45%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
-33.04%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.